Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
$9.59
-2.7%
$10.85
$8.80
$32.71
$427.20M3.291.20 million shs87,184 shs
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
$11.04
-0.2%
$9.93
$8.12
$18.23
$380.24M0.54428,445 shs131,645 shs
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
$17.51
+1.9%
$16.78
$14.42
$23.70
$449.73M0.99163,989 shs40,062 shs
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
$2.19
+12.6%
$1.62
$1.17
$7.78
$141.55M1.1770,565 shs392,390 shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
+2.07%-4.28%+11.17%-33.36%-28.57%
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
-3.66%+2.41%+10.16%+9.50%-25.47%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-3.54%+9.59%+7.58%+0.59%-22.05%
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
-3.48%+4.30%+7.18%-7.18%-71.60%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
$9.59
-2.7%
$10.85
$8.80
$32.71
$427.20M3.291.20 million shs87,184 shs
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
$11.04
-0.2%
$9.93
$8.12
$18.23
$380.24M0.54428,445 shs131,645 shs
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
$17.51
+1.9%
$16.78
$14.42
$23.70
$449.73M0.99163,989 shs40,062 shs
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
$2.19
+12.6%
$1.62
$1.17
$7.78
$141.55M1.1770,565 shs392,390 shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
+2.07%-4.28%+11.17%-33.36%-28.57%
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
-3.66%+2.41%+10.16%+9.50%-25.47%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-3.54%+9.59%+7.58%+0.59%-22.05%
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
-3.48%+4.30%+7.18%-7.18%-71.60%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
2.67
Moderate Buy$22.00129.48% Upside
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
2.67
Moderate Buy$22.50103.80% Upside
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
2.82
Moderate Buy$24.4439.58% Upside
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
1.86
Reduce$4.77118.31% Upside

Current Analyst Ratings Breakdown

Latest TMCI, BBNX, KIDS, and DCTH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/1/2026
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
Set Price Target$17.00
5/1/2026
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
Reiterated RatingBuy$24.00
4/24/2026
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
Set Price Target$25.00
4/22/2026
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
Lower Price TargetOutperform$25.00 ➝ $24.00
4/22/2026
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
Lower Price TargetBuy$22.00 ➝ $20.00
4/21/2026
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
DowngradeSell (D-)Sell (E+)
4/21/2026
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
Reiterated RatingSell (E+)
4/20/2026
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
Reiterated RatingSell (E+)
4/15/2026
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
Lower Price TargetBuy$25.00 ➝ $18.00
4/9/2026
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
Lower Price TargetBuy$23.00 ➝ $20.00
3/27/2026
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
Reiterated RatingSell (D-)
(Data available from 5/12/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
$100.25M4.26N/AN/A$6.53 per share1.47
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
$85.23M4.47$0.05 per share219.61$3.15 per share3.50
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
$236.35M1.90$0.16 per share107.11$13.82 per share1.27
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
$207.32M0.68N/AN/A$1.37 per share1.59
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
-$73.20M-$1.51N/AN/AN/A-60.27%-23.00%-20.55%N/A
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
$2.70M$0.011,101.50110.40N/A0.62%0.51%0.46%N/A
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-$39.65M-$1.68N/AN/AN/A-16.31%-7.01%-4.86%N/A
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
-$59M-$0.97N/AN/AN/A-29.44%-64.43%-29.76%N/A

Latest TMCI, BBNX, KIDS, and DCTH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2026Q1 2026
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
-$0.31-$0.28+$0.03-$0.28$45.96 million$47.20 million
5/7/2026Q1 2026
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
-$0.0971-$0.03+$0.0671-$0.03$23.51 million$24.99 million
4/30/2026Q1 2026
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-$0.4552-$0.42+$0.0352-$0.45$58.29 million$59.36 million
4/21/2026Q1 2026
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
-$0.53-$0.49+$0.04-$0.49N/A$27.63 million
2/27/2026Q4 2025
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
-$0.15-$0.15N/A-$0.15$61.76 million$62.52 million
2/26/2026Q4 2025
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
-$0.06-$0.05+$0.01-$0.05$20.35 million$20.73 million
2/26/2026Q4 2025
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-$0.37-$0.26+$0.11-$0.43$61.27 million$61.61 million
2/17/2026Q4 2025
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
-$0.42-$0.30+$0.12-$0.30N/A$32.12 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
N/AN/AN/AN/AN/A
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
N/AN/AN/AN/AN/A
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
N/AN/AN/AN/AN/A
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
N/A
10.69
9.67
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
N/A
11.24
10.33
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
0.29
5.21
2.37
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
0.64
4.31
3.13

Institutional Ownership

CompanyInstitutional Ownership
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
N/A
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
61.12%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
69.05%
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
84.08%

Insider Ownership

CompanyInsider Ownership
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
5.30%
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
19.36%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
31.80%
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
23.42%
CompanyEmployeesShares OutstandingFree FloatOptionable
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
29444.56 million42.20 millionN/A
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
6034.52 million27.84 millionOptionable
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
20025.68 million17.52 millionOptionable
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
25064.78 million49.61 millionOptionable

Recent News About These Companies

Treace Medical Concepts: Q1 Earnings Snapshot

New MarketBeat Followers Over Time

Media Sentiment Over Time

Beta Bionics stock logo

Beta Bionics NASDAQ:BBNX

$9.59 -0.26 (-2.67%)
As of 11:55 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.

Delcath Systems stock logo

Delcath Systems NASDAQ:DCTH

$11.04 -0.02 (-0.18%)
As of 11:54 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. It also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.

OrthoPediatrics stock logo

OrthoPediatrics NASDAQ:KIDS

$17.51 +0.33 (+1.94%)
As of 11:54 AM Eastern
This is a fair market value price provided by Massive. Learn more.

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

Treace Medical Concepts stock logo

Treace Medical Concepts NASDAQ:TMCI

$2.18 +0.25 (+12.63%)
As of 11:54 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.